NCT06172777Completed
A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD
Source: ClinicalTrials.gov · Last updated 24 Jul 2025
Brief summary (registry, in English)
The study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD, it is a multi-centre clinical study. sponsor by Astrazeneca Investment(China) Co.,LTD.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 801 (actual)
- First submitted
- 7 Dec 2023
- Start date
- 8 Feb 2024
- Primary completion date
- 30 Aug 2024
- Lead sponsor
- AstraZeneca
- Diseases
- Asthma
- NCT number
- NCT06172777
What you commit to
- Study type: Observational
- Participants enrolled: 801
- From 8 Feb 2024 to the primary completion date, 30 Aug 2024
- 41 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any diseases that influence lung function result such as lung cancer, pneumonia, active pulmonary tuberculosis, pulmonary embolism and interstitial lung disease, etc; history of recent surgery that affect lung function results, including thoracotomy surgery, pneumothorax surgery, thoracic drainage, etc
- Contraindication to spirometry or oscillometry test, or allergic to bronchodilator.
Other
- Participants are excluded from the study if any of the following criteria apply:
- Currently pregnant or breast-feeding women
- Judge by the investigator if the participant is unlikely to comply with study procedures, restrictions, and requirements, will not be enrolled .
Who the study is looking for
- Participants are eligible to be included in the study only if all of the following criteria apply and signed informed content :
- Suspected and confirmed asthma
- Participant must be≥18 years old.
- Present symptom such as wheezing, cough, chest tightness, shortness of breath, but not confirmed-asthma (without evidence of variable airflow restriction) or confirmed-asthma with evidence of variable airflow restriction (such as positive bronchodilation test, positive bronchial challenge test, variability \>10% in twice daily PEF over 2 weeks, et al) Suspected and confirmed COPD
- 1 Participant must be ≥40 years old. 2 Present symptom such as chronic cough, sputum production, dyspnoea, but not confirmed-COPD (without evidence of persistent airflow restriction) or confirmed- COPD with evidence of persistent airflow restriction (post-bronchodilator FEV1/FVC\<0.7)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (41)
Sites in registry order. Pick your city on the disease page to sort them by distance.
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.